A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
Tweed, C. D., Wills, G. H., Crook, A. M., Amukoye, E., Balanag, V., Ban, A. Y.L., Bateson, A. L.C., Betteridge, M. C., Brumskine, W., Caoili, J., Chaisson, R. E., Cevik, M., Conradie, F., Dawson, R., del Parigi, A., Diacon, A., Everitt, D. E., Fabiane, S.M., Hunt, R., Ismail, A. I., Lalloo, U., Lombard, L., Louw, C., Malahleha, M., McHugh, T. D., Mendel, C. M., Mhimbira, F., Moodliar, R. N., Nduba, V., Nunn, A. J., Sabi, I., Sebe, M. A., Selepe, R. A. P., Staples, S., Swindells, S., van Niekerk, C. H., Variava, E., Spigelman, M., Gillespie, S. H.
Published in The international journal of tuberculosis and lung disease (01.04.2021)
Published in The international journal of tuberculosis and lung disease (01.04.2021)
Get full text
Journal Article